Materna Medical, an OBGYN platform company dedicated to protecting women's pelvic health, announced the completion of the activation of the fifteenth U.S. clinical study site participating in the pivotal EASE trial. This clinical study is evaluating the safety and effectiveness of the Prep device and will investigate whether use of the device can reduce pelvic floor damage for first-time mothers during labor and delivery.
Search
Recent Posts
See AllSpring has sprung across the U.S., and many of you are probably ready to hit the course and outdoor courts. But a recent injury may be interrupting your golf game or tennis match. If you’re hesitant o
TripleBlind, creator of the most complete and scalable solution for privacy enhancing computation, announced acceptance to present at IEEE’s 42nd International Conference on Distributed Computing Syst
The Mighty, the world's leading health community bringing the patient's voice to life across the healthcare industry, has hired Matthew Michelson, Ph.D. as President. Dr. Michelson is a pioneer in the
